Connection

Gary Gilkeson to Mice, Inbred MRL lpr

Back to Details
This is a "connection" page, showing publications Gary Gilkeson has written about Mice, Inbred MRL lpr.
Gary Gilkeson
Connection Strength
2.254
Mice, Inbred MRL lpr
  1. Use of genetic knockouts to modulate disease expression in a murine model of lupus, MRL/lpr mice. Immunol Res. 2002; 25(2):143-53.
    View in: PubMed
    Score: 0.186
  2. Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL/lpr lupus mice. PLoS One. 2020; 15(3):e0230499.
    View in: PubMed
    Score: 0.164
  3. Effect of a genetic deficiency of terminal deoxynucleotidyl transferase on autoantibody production by C57BL6 Fas(lpr) mice. Clin Immunol. 2000 Jan; 94(1):24-32.
    View in: PubMed
    Score: 0.162
  4. Differential efficacy of human mesenchymal stem cells based on source of origin. J Immunol. 2014 Nov 01; 193(9):4381-90.
    View in: PubMed
    Score: 0.112
  5. NADPH oxidase and nitric oxide synthase-dependent superoxide production is increased in proliferative lupus nephritis. Lupus. 2013 Nov; 22(13):1361-70.
    View in: PubMed
    Score: 0.105
  6. Endothelial nitric oxide synthase reduces crescentic and necrotic glomerular lesions, reactive oxygen production, and MCP1 production in murine lupus nephritis. PLoS One. 2013; 8(5):e64650.
    View in: PubMed
    Score: 0.103
  7. Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL/lpr and (NZB/NZW)F1 mice. Clin Immunol. 2012 Nov; 145(2):142-52.
    View in: PubMed
    Score: 0.098
  8. Selective cyclooxygenase-2 inhibitor suppresses renal thromboxane production but not proliferative lesions in the MRL/lpr murine model of lupus nephritis. Am J Med Sci. 2011 Feb; 341(2):101-5.
    View in: PubMed
    Score: 0.087
  9. Lifetime exposure to trichloroethylene (TCE) does not accelerate autoimmune disease in MRL +/+ mice. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2008 Oct; 43(12):1402-9.
    View in: PubMed
    Score: 0.074
  10. Role of MHC-linked genes in autoantigen selection and renal disease in a murine model of systemic lupus erythematosus. J Immunol. 2006 Nov 15; 177(10):7423-34.
    View in: PubMed
    Score: 0.065
  11. Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. Arthritis Rheum. 2006 Jul; 54(7):2198-210.
    View in: PubMed
    Score: 0.063
  12. Interferon regulatory factor-1 gene deletion decreases glomerulonephritis in MRL/lpr mice. Eur J Immunol. 2006 May; 36(5):1296-308.
    View in: PubMed
    Score: 0.063
  13. Inflammatory modulation of PPAR gamma expression and activity. Clin Immunol. 2006 Feb-Mar; 118(2-3):276-83.
    View in: PubMed
    Score: 0.061
  14. Decreased expression of the Ets family transcription factor Fli-1 markedly prolongs survival and significantly reduces renal disease in MRL/lpr mice. J Immunol. 2004 Nov 15; 173(10):6481-9.
    View in: PubMed
    Score: 0.057
  15. Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid. J Immunol. 2004 Sep 15; 173(6):4171-8.
    View in: PubMed
    Score: 0.056
  16. Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL/MpJ-Fas(lpr) mice. J Immunol. 2004 Mar 15; 172(6):3913-21.
    View in: PubMed
    Score: 0.054
  17. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice. Kidney Int. 2004 Jan; 65(1):129-38.
    View in: PubMed
    Score: 0.053
  18. Nitric oxide induces apoptosis in spleen lymphocytes from MRL/lpr mice. J Investig Med. 2004 Jan; 52(1):62-71.
    View in: PubMed
    Score: 0.053
  19. Effect of genetic deficiency of terminal deoxynucleotidyl transferase on autoantibody production and renal disease in MRL/lpr mice. Clin Immunol. 2003 Jun; 107(3):186-97.
    View in: PubMed
    Score: 0.051
  20. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J Clin Invest. 2003 Feb; 111(4):539-52.
    View in: PubMed
    Score: 0.050
  21. Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody production via autoreactive B cell receptor clonal selection, implications in systemic lupus erythematosus. J Autoimmun. 2022 07; 131:102860.
    View in: PubMed
    Score: 0.048
  22. Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice. J Immunol. 2001 May 15; 166(10):6444-51.
    View in: PubMed
    Score: 0.044
  23. Prostaglandin J(2) inhibition of mesangial cell iNOS expression. Clin Immunol. 2001 Mar; 98(3):337-45.
    View in: PubMed
    Score: 0.044
  24. Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-gamma agonists. J Immunol. 2000 Feb 01; 164(3):1498-504.
    View in: PubMed
    Score: 0.041
  25. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J Immunol. 2000 Jan 15; 164(2):786-94.
    View in: PubMed
    Score: 0.041
  26. Clinical and serologic manifestations of autoimmune disease in MRL-lpr/lpr mice lacking nitric oxide synthase type 2. J Exp Med. 1997 Aug 04; 186(3):365-73.
    View in: PubMed
    Score: 0.034
  27. Effect of late modulation of nitric oxide production on murine lupus. Clin Immunol Immunopathol. 1997 Apr; 83(1):86-92.
    View in: PubMed
    Score: 0.033
  28. A critical role of the transcription factor fli-1 in murine lupus development by regulation of interleukin-6 expression. Arthritis Rheumatol. 2014 Dec; 66(12):3436-44.
    View in: PubMed
    Score: 0.028
  29. Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation. Cell Transplant. 2013; 22(12):2279-90.
    View in: PubMed
    Score: 0.025
  30. The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice. Arthritis Rheum. 2011 Apr; 63(4):1076-85.
    View in: PubMed
    Score: 0.022
  31. Impact of Fli-1 transcription factor on autoantibody and lupus nephritis in NZM2410 mice. Clin Exp Immunol. 2010 Nov; 162(2):362-71.
    View in: PubMed
    Score: 0.021
  32. Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice. Lupus. 2010 Nov; 19(13):1502-14.
    View in: PubMed
    Score: 0.021
  33. Decreased expression of Fli-1 in bone marrow-derived haematopoietic cells significantly affects disease development in Murphy Roths Large/lymphoproliferation (MRL/lpr) mice. Clin Exp Immunol. 2010 May; 160(2):275-82.
    View in: PubMed
    Score: 0.020
  34. Inducible nitric oxide synthase inhibitor SD-3651 reduces proteinuria in MRL/lpr mice deficient in the NOS2 gene. J Investig Med. 2008 Oct; 56(7):911-9.
    View in: PubMed
    Score: 0.019
  35. Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL/lpr mice. J Immunol. 2008 Jan 15; 180(2):1231-8.
    View in: PubMed
    Score: 0.018
  36. Absence of functional alternative complement pathway alleviates lupus cerebritis. Eur J Immunol. 2007 Jun; 37(6):1691-701.
    View in: PubMed
    Score: 0.017
  37. Role for Msh5 in the regulation of Ig class switch recombination. Proc Natl Acad Sci U S A. 2007 Apr 24; 104(17):7193-8.
    View in: PubMed
    Score: 0.017
  38. Decay-accelerating factor ameliorates systemic autoimmune disease in MRL/lpr mice via both complement-dependent and -independent mechanisms. Am J Pathol. 2007 Apr; 170(4):1258-66.
    View in: PubMed
    Score: 0.017
  39. Genomic view of systemic autoimmunity in MRLlpr mice. Genes Immun. 2006 Mar; 7(2):156-68.
    View in: PubMed
    Score: 0.016
  40. Peroxynitrite formation and decreased catalase activity in autoimmune MRL-lpr/lpr mice. Mol Med. 2000 Sep; 6(9):779-92.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.